Polen Capital Management LLC lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS – Get Rating) by 65.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 211,853 shares of the company's stock after purchasing an additional 84,133 shares during the period. Polen Capital Management LLC owned 0.11% of Doximity worth $6,402,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently made changes to their positions in the company. Janney Montgomery Scott LLC bought a new position in shares of Doximity during the second quarter worth approximately $576,000. Yarbrough Capital LLC acquired a new stake in Doximity during the third quarter worth approximately $259,000. Zeke Capital Advisors LLC grew its position in Doximity by 20.2% during the second quarter. Zeke Capital Advisors LLC now owns 36,365 shares of the company's stock worth $1,266,000 after buying an additional 6,107 shares in the last quarter. Private Advisor Group LLC grew its position in Doximity by 32.8% during the second quarter. Private Advisor Group LLC now owns 18,313 shares of the company's stock worth $638,000 after buying an additional 4,527 shares in the last quarter. Finally, Renaissance Capital LLC grew its position in Doximity by 488.1% during the third quarter. Renaissance Capital LLC now owns 41,317 shares of the company's stock worth $1,249,000 after buying an additional 34,291 shares in the last quarter. Institutional investors own 52.48% of the company's stock.
Get Doximity alerts:Doximity Trading Up 0.5 %
NASDAQ:DOCS traded up $0.16 during trading hours on Monday, hitting $32.45. 53,263 shares of the company were exchanged, compared to its average volume of 1,023,947. The stock has a market capitalization of $6.25 billion, a price-to-earnings ratio of 49.68, a price-to-earnings-growth ratio of 16.85 and a beta of 0.86. Doximity, Inc. has a one year low of $22.91 and a one year high of $64.95. The company has a fifty day simple moving average of $33.29 and a 200 day simple moving average of $33.37.
Doximity (NASDAQ:DOCS – Get Rating) last announced its earnings results on Thursday, November 10th. The company reported $0.12 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.12. The business had revenue of $102.19 million during the quarter, compared to analyst estimates of $99.86 million. Doximity had a return on equity of 16.41% and a net margin of 36.70%. Equities research analysts predict that Doximity, Inc. will post 0.52 earnings per share for the current fiscal year.Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on DOCS shares. Wells Fargo & Company increased their price target on Doximity from $38.00 to $44.00 and gave the stock an "overweight" rating in a research report on Friday, November 11th. BTIG Research assumed coverage on Doximity in a report on Thursday, October 13th. They issued a "neutral" rating on the stock. Evercore ISI raised their target price on Doximity from $28.00 to $32.00 in a report on Friday, November 11th. Morgan Stanley downgraded Doximity from an "equal weight" rating to an "underweight" rating and reduced their target price for the company from $32.00 to $29.00 in a report on Friday, January 6th. Finally, Piper Sandler reduced their target price on Doximity from $39.00 to $35.00 in a report on Friday, November 11th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, Doximity presently has an average rating of "Hold" and an average target price of $41.40.
Doximity Profile
(Get Rating)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading
- Get a free copy of the StockNews.com research report on Doximity (DOCS)
- Tractor Supply Company Shares Could be Headed to New Highs
- Is Canadian Solar Too Hot to Handle?
- UiPath is the Blue-Collar AI Platform to Watch in 2023
- CVS Health is Growing into an Integrated Healthcare Organization
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Get Rating).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.